QRxPharma Company Profile

02:45 EST 25th November 2017 | BioPortfolio

News Articles [2 Associated News Articles listed on BioPortfolio]

QRxPharma Ltd QRX Financial and Strategic SWOT Analysis Review [Report Updated: 25102017] Prices from USD $125

QRxPharma Ltd QRX Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

QRxPharma Ltd QRX Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummaryQRxPharma Ltd QRxPharma is a pharmaceutical company. It develops and commercializes treatments for pain management and abuse prevention products. The company's product portfolio includes late a...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Extension Study to Evaluate the Safety of Q8003 in Patients With Acute Moderate to Severe Pain

This is a Phase 3 double-blind, multiple dose safety extension study of Q8003 administered at daily doses up to 36 mg morphine/24 mg oxycodone (Q8003 36mg/24mg) over a treatment period of ...

Companies [2 Associated Companies listed on BioPortfolio]

QRxPharma Limited

QRxPharma (ASX: QRX and OTCQX: QRXPY) is a clinical-stage specialty pharmaceutical company focused on the development and commercialisation of therapies for pain management and central nervous system ...


More Information about "QRxPharma" on BioPortfolio

We have published hundreds of QRxPharma news stories on BioPortfolio along with dozens of QRxPharma Clinical Trials and PubMed Articles about QRxPharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of QRxPharma Companies in our database. You can also find out about relevant QRxPharma Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record